Delivery Order SPE2DB24D1201-SPE2DB25FJAGX

Award Date 10/29/24
Potential Completion Date 10/30/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,188.27 firm-fixed-price delivery order is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a diabetes medication. The contract has an ultimate completion date of December 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,292.99 firm fixed price delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used in the treatment of diabetes. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,023.63 firm fixed-price delivery order covers the supply of the drug Ozempic, a specialty medication used for diabetes management. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,113.22 Firm Fixed Price Delivery Order is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,994.51 firm fixed-price delivery order is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to manage diabetes. The award has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,659.18 Firm Fixed Price delivery order is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 1.5ML, a prescription medication used for diabetes management. The contract has an ultimate completion date of July 22, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,866.06 firm fixed price delivery order is for the supply of Ozempic, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of March 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as...
This federal contract award, with ID SPE2DB20D2001|SPE2DB24FPLKZ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $40,669.11 firm fixed-price delivery order is for Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The contract has a completion date of September 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,312.05 Firm Fixed Price Delivery Order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The contract has an ultimate completion date of December 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,879.98 firm fixed-price delivery order is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used for the treatment of diabetes. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB25FJAGX
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,741.62 firm fixed-price delivery order is for the supply of Ozempic, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of October 30, 2024.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 1/28/25, 12:16 PM